NYSE · Medical - Instruments & Supplies

Avantor, Inc. (AVTR) Stock

$17.29 +0.82% NYSE: AVTR Healthcare

Valuation

MetricValue
Price$17.29
Market Cap$11.69B
P/E Ratio-18.29
P/B Ratio1.84
P/S Ratio1.58
EPS (TTM)$-0.78
52-Week High$17.30
52-Week Low$7.26
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10.34%
ROA-4.98%
ROCE-2.80%
Gross Margin-3.75%
Operating Margin-3.75%
Net Margin-8.81%
Debt/Equity0.66
Current Ratio1.78

Annual Financials (USD)

Metric20212022202320242025
Revenue$7.4B$7.5B$7.0B$6.8B$6.6B
Operating Profit$972.0M$1.1B$696.0M$1.1B$-246.0M
Net Profit$573.0M$687.0M$321.0M$712.0M$-530.0M
EPS$0.85$1.01$0.47$1.04$-0.78
Op Margin13.2%15.0%10.0%16.0%-3.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.9B$13.5B$13.0B$12.1B$11.8B
Total Liabilities$9.7B$8.6B$7.7B$6.2B$6.2B
Cash$302.0M$373.0M$263.0M$262.0M$365.0M
Borrowings$7.0B$6.3B$5.5B$4.1B$3.9B

Latest News

Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report? Zacks · Jul 15, 2026 Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership Zacks · Jul 15, 2026 AVTR: Raising target price to $12.00 Argus Research · Jul 15, 2026 Avantor's NuSil Brand Expands HIV Prevention Collaboration With Population Council MT Newswires · Jul 14, 2026 Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product PR Newswire · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$954.0M$844.0M$870.0M$841.0M$624.0M
Investing Cash Flow$-4.2B$-243.0M$-290.0M$290.0M$-259.0M
Financing Cash Flow$16.0M$4.0M$2.0M$61.0M$-96.0M
Net Cash Flow$38.0M$70.0M$-109.0M$-23.0M$104.0M
Free Cash Flow$843.0M$710.0M$724.0M$692.0M$495.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.36
EV / EBITDA109.87
FCF Yield4.38%
Quick Ratio1.18
Interest Coverage-1.60
Return 1Y15.73%
Return 3Y-24.52%
Return 5Y-62.35%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AZTAAzenta, Inc. $36.50 +1.36% -14.09 $1.60B 0.00%
BIOBio-Rad Laboratories, Inc. $369.95 +1.77% 44.31 $9.89B 0.00%
BLFSBioLife Solutions, Inc. $38.61 +0.00% 36.07 $1.89B 0.00%
CRLCharles River Laboratories International, Inc. $345.37 +1.68% -59.96 $16.64B 0.00%
DHRDanaher Corporation $230.50 +0.33% 39.76 $162.04B 0.71%

About Avantor, Inc.

Avantor, Inc. is led by CEO Emmanuel Ligner, employs 13,500 people, headquartered in Radnor, US, publicly traded since 2019.

Avantor, Inc. (AVTR) stock trades at $17.29 with a market capitalization of $11.69B. The stock is valued at a negative price-to-earnings (P/E) ratio of -18.29, reflecting a net loss over the last twelve months, price-to-book of 1.84, price-to-sales of 1.58. Over the past 52 weeks the stock has ranged between $7.26 and $17.30, and currently trades at or near its 52-week high.

On profitability, Avantor, Inc. generates a return on equity (ROE) of -10.34% (negative, reflecting a net loss), return on capital employed of -2.80%, an operating margin of -3.75%, a net profit margin of -8.81%.

Avantor, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Avantor, Inc. reported revenue of $691.0M rising to $6.6B, a change of +848.2% across 10 years. Compounded, revenue has grown 0.5% a year over five years, -4.5% over three, -3.4% over the last twelve months. Net profit fell to $-530.0M.

Operating margin went from 1.4% in 2016 to -3.8% in 2025, a fall of 5.2 percentage points. The most recent net margin is -8.81%. On a trailing twelve-month basis to Jun '26, revenue is $6.6B and net profit $-579.0M.

Borrowings rose from $1.3B to $3.9B, cash from operations was $624.0M in the latest year, positive in 9 of the last 10.

Return on equity has averaged 7.3% over five years, and was -9.5% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Avantor, Inc. (AVTR) — frequently asked questions

What is Avantor, Inc. (AVTR) stock price today?

Avantor, Inc. (AVTR) is currently trading at $17.29, up 0.82% today.

What is AVTR P/E ratio?

Avantor, Inc.'s P/E ratio is -18.29. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is AVTR return on equity (ROE)?

Avantor, Inc.'s return on equity (ROE) is -10.34%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Avantor, Inc.'s market cap?

Avantor, Inc. has a market capitalization of $11.69B.

Does AVTR pay a dividend?

Avantor, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does AVTR carry?

Avantor, Inc. has a debt-to-equity ratio of 0.66. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is AVTR's profit margin?

Avantor, Inc. reports a net profit margin of -8.81% — the share of revenue left after every cost, including tax and interest.

What sector is AVTR in?

Avantor, Inc. is classified under Healthcare, in the Medical - Instruments & Supplies industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is AVTR listed on?

Avantor, Inc. trades on NYSE under the ticker AVTR.

What is AVTR's 52-week range?

Over the last year Avantor, Inc. has traded between $7.26 and $17.30.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens AVTR currently matches

On the figures above, Avantor, Inc. passes the filters for 5 of our ready-made screens, among them Large Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Large Cap StocksStocks Under $100Stocks Under $50NYSE Listed StocksDebt to Equity Below 1 Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.